TSPO and Parkinson disease: Initial studies employing the first-generation TSPO ligand (R)-[^11C]PK11195 reported heightened tracer uptake in various brain regions, including the midbrain, pons, and cortex, in PD patients relative to healthy controls, supporting the notion that neuroinflammation plays a role in PD pathology [165].